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 Abstract
Magnetic resonance belongs to a group of modern diagnostic methods which, together with classic gynecological, 
transvaginal ultrasound and histopathological examinations, should be routinely used in patients with suspicion or 
diagnosed cervical malignancies. The procedure allows precise localization and staging of the tumor, as well as 
evaluation of the volume of the local lymph nodes. Obtained data are useful in selection of optimal therapy and 
evaluation of cancer progression.
Intravenous injection of the paramagnetic contrast media significantly increases diagnosis accuracy, especially of 
small lesions. It is also helpful in differentiation of post-radiotherapy changes and malignant infiltration. The new 
applications, such as diffusion weighted imaging, magnetic resonance spectroscopy and fat or water saturation are 
also widely used to improve final diagnosis. 
The endovaginal receiver coil allows high spatial resolution imaging of the cervix, which is particularly useful in very 
small, controversial lesions.
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 Streszcznie
Tomografia rezonansu magnetycznego należy do nowoczesnych metod obrazowania ciała, która wraz z podmioto-
wym badaniem ginekologicznym, ultrasonografią przezpochowową i oceną histopatologiczną powinna być rutyno-
wo stosowana w diagnostyce pacjentek z podejrzeniem lub potwierdzonym złośliwym rozrostem w obrębie szyjki 
macicy. 
Metoda umożliwia dokładną ocenę lokalizacji i zaawansowania nowotworu oraz objętości okolicznych węzłów 
chłonnych. Uzyskane dane pozwalają na wybór najlepszego sposobu leczenia oraz są istotne przy ocenie postępu 
choroby. Podanie paramagnetycznych środków kontrastowych znacząco poprawia diagnostykę małych zmian. 
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Cervical	cancer	is	the	second	most	common	malignancy	in	
women	worldwide,	with	incidence	peak	between	45-50	years	of	
age	[1].	 In	Poland	is	sixth	on	 the	 list	of	morbidity	and	seventh	
of	 mortality	 rates	 [2,3].	 In	 highly	 developed	 countries,	 where	
prophylaxis,	 treatment	 funds	 and	 social	 awareness	 are	 higher,	
a	considerable	 reduction	 in	both	cervical	 cancer	morbidity	and	
mortality	has	been	observed	[4].
Success	of	the	treatment	lies	mainly	in	diagnosing	the	lesion	
at	the	earliest	possible	stage.	In	order	to	achieve	that,	prophylactic	
tests	are	carried	out,	 including	pelvic	organs	assessment	on	the	
basis	of	classic	gynecological,	cytological	and	ultrasonographic	
examination	[2,4].
In	recent	years	the	combined	therapy	has	become	the	treatment	
of	 choice	 (chemo-	 and	 radiotherapy)	 and	 has	 significantly	
improved	 treatment	 results	 of	 patients	 in	 advanced	 stages.	 It	
considerably	reduces	the	risk	of	late-onset	complications	which	
further	 indicates	 the	 importance	 of	 disease	 staging	 in	 order	 to	
select	the	best	method	of	treatment	[5].	Due	to	the	lack	of	specific	
markers	 for	 cervical	 cancer,	 it	 is	 the	 clinical	 examination	 and	
modern	 methods	 of	 imaging,	 particularly	 magnetic	 resonance	
(MR),	that	play	the	most	important	role	in	the	process	of	diagnosis	
[4-7].
Cervical cancer imaging in magnetic 
resonance
Magnetic	 resonance	 is	 a	 test	 based	 on	 proton	 magnetic	
properties	which,	according	to	the	current	state	of	knowledge,	is	
harmless	for	human	body.	The	test	is	useful	in	an	early	detection	
of	 focal	 lesions.	 It	 is	 also	 believed	 to	 be	 the	 best	 method	 of	
assessing	the	stage	of	cervical	cancer	as	it	provides	good	spatial	
and	contrast	resolution	and	the	possibility	of	multi-dimensional	
imaging.	 It	 is	 estimated	 that	MR	sensitivity	 and	 specificity	 for	
changes	 in	 lesser	pelvis	are	75–80%	and	94–96%,	respectively	
[6].	 In	 patients	 with	 diagnosed	 cervical	 cancer	 the	 obtained	
images	 allow	 to	 precisely	 determine	 the	 location	 and	 size	 of	
the	tumor,	which	is	clearly	separated	and	visible,	as	well	as	the	
range	 of	 neoplastic	 infiltration	 of	 the	 adjacent	 structures.	 The	
examination	 is	 the	 method	 of	 choice	 for	 treatment	 planning,	
monitoring	 and	 check-up	 [7,	 8].	MR	 imaging	 is	 more	 precise	
than	clinical	examination	and	computed	tomography	(CT).	MR	
precision	has	been	estimated	 to	be	92%,	whereas	 it	 is	78%	for	
clinical	examination	and	70%	for	CT	[9].
Prior	 to	undergoing	an	MRI	examination,	a	patient	 should	
be	fasting	and	have	a	moderately	filled	urinary	bladder.	1	mg	of	
glucagon	is	administered	intramuscularly	to	minimize	peristalsis-
related	artifacts.	In	routine	imaging	the	enteral	contrast	media	are	
not	administered.	However,	Gd-DTPA	–	a	complex	of	gadolinium	
with	diethylenetriamine	chelating	agent	pentaacetic	acid	–	may	
be	administered	if	there	is	a	suspicion	of	lesions	originating	from	
the	bowel	or	the	ovary	[7,	10].
Similarly	 to	 other	 parts	 of	 the	 body,	MR	 of	 the	 pelvis	 is	
performed	 using	 spin-echo	 sequence,	 T1	 and	 T2-weighted	
images,	 in	 multi-dimensions	 (sagittal,	 coronal,	 axial),	 with	 a	
section	thickness	of	5-6	mm	and	a	1,5	mm	gap	[6,	7,	9].
On	 T1-weighted	 images	 tumor	 lesions	 have	 low	 signal	
intensity	(Figure	1),	heterogenic	structure	and	appear	isointensive	
in	 comparison	 with	 a	 normal	 cervical	 canal	 structure	 [7].	 T2-
weighted	images	are	used	for	assessment	of	organ	morphology,	
particularly	three	primary	layers	of	the	uterus.	
Jest również pomocne w różnicowaniu zmian popromiennych od naciekowych. 
Diagnostykę poszerza się również o ocenę dyfuzji, obrazowanie w opcji saturacji tłuszczu i wody oraz spektroskopię 
rezonansu magnetycznego. 
W małych zmianach zalecane jest również wykonanie badania dodatkową sondą pochwową.
 Słowa kluczowe: rak szyjki macicy / rezonans magnetyczny / 
    / zaawansowanie nowotworu / diagnostyka / 
Figure 1. Low differentiation of the cervical cancer from unaffected part of the 
uterine cervix in the T1-weighted image.  
Figure 2. Oval-shaped, poorly-demarcated tumor on the right part of the uterine 
cervix in the T2-weighted image.  
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Cervical	 cancer	 in	 T2-weighted	 images	 has	 high	 signal	
intensity	 in	 the	 cervical	 stroma.	 T2-weighted	 images	 are	 the	
most	 significant	 in	 the	 assessment	 of	 parametrium,	 and	 the	
discontinuity	of	the	hypointensive	rims	is	a	signal	of	the	invasion.	
The	same	rule	(presence	of	hypointensive	rims	on	T2-weighted	
images)	is	also	valid	when	assessing	an	invasion	of	 the	rectum	
and/or	urinary	bladder.	(Figure	2,	3A).
Additional	sequences	are	used	for	better	assessment	of	tumor	
morphology,	especially	features	such	as	hypoxia	or	angiogenesis	
[11],	and	it	is	achieved	by	water	or	fat	saturation	imaging.	(Figure.	
3B).	
They	allow	to	differentiate	regions	containing	the	fatty	tissue	
fatty	tissue,	free	lipids	and	blood.	A	gel-filled	tampon	(the	same	
gel	 as	 the	 one	 used	 for	 ultrasonographic	 examination)	may	 be	
placed	 to	 determine	 the	 extent	 of	 the	 invasion	 in	 the	 vagina.	
After	administering	paramagnetic	contrast	medium	(gadolinium	
chelate),	the	structures	in	the	tumor	are	clearly	enhanced	in	most	
cases.	This	allows	to	better	determine	the	rim	of	the	lesion	as	well	
as	the	adjacent	structures	infiltration.	(Figure	5).	
Contrast-agent	is	particularly	useful	in	monitoring	of	patients	
after	radiotherapy	in	order	to	differentiate	between	post-radiation	
and	scar	changes	with	the	disease	recurrence	[9].
The	 cervical	 cancer	 staging,	 currently	 used	 in	 a	
radiological	 assessment,	 is	 similar	 to	 the	 clinical-surgical	 and	
pathomorphological	classification	of	the	International	Federation	
of	Gynecology	and	Obstetrics	(FIGO).	
In	 accordance	 with	 the	 latest	 recommendations,	 both	 the	
volume	of	the	tumor	and	adjacent	lymph	nodes	are	assessed	on	
the	 basis	 of	 the	 obtained	 images	 and	 later	 reconstructions	 [12,	
13].	Both	parameters	have	a	decisive	influence	on	the	choice	of	
treatment	method	and	constitute	an	important	prognostic	factor	
[14].	As	mentioned	before,	the	routinely	used	diagnostic	methods	
–	 clinical	 examination,	 CT	 and	 ultrasonography	 –	 have	 lower	
precision	when	compared	to	MR,	which	also	allows	to	measure	
water	diffusion.	(Figure	4.).	
In	certain	cases,	MR	spectroscopy	and	endovaginal	receiver	
coil	are	employed	since	they	allow	for	more	detailed	diagnosis.
Measurement of tumor and lymph node 
volume
On	 the	 basis	 of	 a	 retrospective	 study	of	 106	patients	with	
diagnosed	 advanced	 stage	 cervical	 cancer,	Hunjung	 et	 al.	 [15]	
observed	 the	 usefulness	 of	 tumor	 volume	measurement	 before	
commencing	 treatment.	 Patients	 classified	 as	 a	 high-volume	
tumor	 are	 more	 likely	 to	 have	 a	 recurrence	 than	 low-volume	
ones.	Such	findings	were	confirmed	by	Dae	et	al.	[16].
Kamimori	 et	 al.	 [14],	 when	 assessing	 125	 IB1-patients,	
concluded	 that	 tumor	diameter	 -	measured	before	commencing	
treatment	-	has	a	positive	correlation	with	numerous	prognostic	
factors,	 particularly	 with	 the	 infiltration	 of	 the	 parametrium.	
Research	 proves	 that	 tumor	 diameter	 is	 an	 important	 predictor	
which	 may	 be	 used	 when	 choosing	 the	 method	 of	 treatment,	
especially	 in	 case	 of	 patients	 qualified	 for	 less	 radical	 surgery,	
without	 the	 necessity	 to	 perform	 biopsy.	 Pointreau	 et	 al.,	 [12]	
added	the	lymph	node	volume	to	the	group	of	prognostic	factors.	
However,	Goudy	et	al.,	 [17]	after	examining	219	patients	with	
advanced	 stage	 cervical	 carcinoma	 (Ib1-IIb)	 observed	 that	
lymph	nodes	infiltration	is	of	 tremendous	importance	in	a	risk-
assessment	 of	metastases	 and	 response	 to	 treatment.	 Liyanage	
et	 al.,	 [7]	 emphasize	 that,	 despite	 the	 fact	 that	 lymph	 nodes	
imaging	has	not	been	included	into	the	FIGO	classification,	their	
morphology	should	always	be	assessed	since	5-year	survival	for	
patients	with	 lymph	 nodes	 infiltration	 is	 estimated	 to	 be	 about	
39-54%.	In	case	of	patients	with	non-infiltrated	lymph	nodes	it	
is	up	to	67-92%.	The	role	of	MR	is	further	underlined	by	the	fact	
that	despite	early	 tumor	detection,	 the	presence	of	 lymph	node	
metastases	excludes	surgical	treatment	and	these	patients	should	
be	qualified	for	the	chemoradiotherapy.	In	more	advanced	stages,	
lymph	nodes	assessment	is	also	helpful	in	planning	the	extent	of	
radiation	areas.
According	to	Camisão	et	al.,	[9]	a	metastatic	lymph	node	is	
at	least	10	mm	in	short	axis.	Nevertheless,	lower	values	of	7.0-10	
mm	are	also	mentioned,	depending	on	the	location.	For	common,	
Figure 3. Poorly-seen margin between the cervical tumor and the bladder and the 
rectum suggesting their infiltration in the T2-weighted (A)  
and in fat saturation images (B). 
B
A
©  P o l s k i e  T o w a r z y s t w o  G i n e k o l o g i c z n e 125
P R A C E  P O G L Ñ D O W E
  g in eko l og ia 
Mocarska A, et al.
Ginekol Pol. 2012, 83, 122-127 
internal	and	external	iliac	lymph	nodes,	the	value	is	9.0,	7.0	and	
10	mm,	respectively.
It	is	worth	to	underline	that	the	imaging	after	administration	
of	paramagnetic	 contrast	 agent	 is	 very	useful	 for	 assessing	 the	
location	and	morphology	of	the	nodes.
In	 order	 to	 optimize	 treatment	 planning,	 the	 nomenclature	
of	 lymph	 nodes	 has	 been	 based	 on	 the	 classic	 anatomical	
classification	by	Takafumi	et	al.	[18].	Pelvic	lymph	nodes	were	
divided	 into	 five	 major	 groups:	 common	 iliac,	 external	 iliac,	
internal	iliac,	obturator	and	parametrial.	Liyanage	et	al.,	[7]	also	
noticed	 that	 cervical	 cancer	 metastases	 are	 usually	 primarily	
located	 in	 parametrial	 nodes,	 followed	 by	 common	 iliac	 and	
obturator	 ones.	 Due	 to	 potentially	 spread	 process	 of	 cancer	
metastases,	 the	 authors	 recommend	 3D-nodes	measurement	 in	
three	dimensions:	antero-posterior,	cranio-caudal	and	transverse.
Diffusion weighted imaging
Diffusion	 weighted	 imaging	 (DWI)	 may	 be	 applied	 to	
assess	the	pelvic	organs.	The	image	contrast	is	achieved	by	the	
assessment	 of	 the	 random	 movement	 of	 water	 molecules	 in	
tissues.	Data	on	concentration	and	density	of	the	cells,	as	well	as	
microcirculation	and	cell	membrane	permeability	are	used	 [19,	
20].	Changes	of	the	apparent	diffusion	coefficient	(ADC1)	have	
been	proven	to	be	connected	with	the	cellular	density	in	case	of	
neoplastic	lesions.	During	the	examination,	the	area	which	takes	
the	 largest	part	of	 the	neoplastic	 lesion	 in	T2-weighted	 images	
is	marked.	The	 rim	of	 the	 lesion	 is	 determined	by	 comparison	
with	T1-	and	T2-weighted	images,	and	then	after	administering	
paramagnetic	 contrast	 agent.	 The	 marked	 area	 is	 then	 copied	
onto	the	ADC	map	and	the	values	are	compared	with	parameters	
obtained	within	 the	 normal	 healthy	 tissue.	 Diffusion	 weighted	
imaging	has	many	advantages,	chief	among	them	the	relatively	
short	 time	 of	 scanning,	 without	 the	 necessity	 of	 intravenous	
administration	of	paramagnetic	contrast	agent,	what	is	particularly	
important	 in	 case	 of	 patients	with	 renal	 failure.	 It	 needs	 to	 be	
emphasized,	that	the	sequence	is	complementary	to	the	standard	
examination	protocol.
Liu	 et	 al.	 [21,	 22],	 after	 examining	 42	 women	 with	
cervical	cancer	and	15	patients	with	uterine	myomas,	are	of	the	
opinion	 that	MR	with	 diffusion	 sequence	 allows	 to	 determine	
the	 histopathologic	 type	 of	 the	 tumor	 on	 the	 basis	 of	 healthy	
cells	 and	 tumor	 cells	 density.	 Messiou	 et	 al.,	 [23]	 presented	
similar	conclusions	regarding	the	usefulness	of	diffusion	in	 the	
assessment	of	uterine	morphology	and	the	possibility	of	an	early	
detection	 of	 the	 neoplastic	 infiltration.	 Liu	 et	 al.,	 [21,	 22]	 and	
Zhang	et	 al.,	 [24]	 reported	 similar	observations.	Moreover,	 the	
authors	state	that	MR	supplemented	with	the	diffusion	sequence	
allows	 to	 predict	 tumor	 response	 to	 treatment.	 Nevertheless,	
these	 results	 come	 from	 research	 carried	 out	 on	 a	 relatively	
small	number	of	patients	 (17	and	14,	 respectively)	and	 require	
verification.	Lin	et	al.	[25],	after	conducting	diffusion	technique	
test	in	50	patients	diagnosed	with	cervical	cancer,	concluded	that	
the	method	 allows	 to	 identify	metastatic	 lymph	 nodes	 (micro-
metastases)	of	even	5	mm.	Apparent	diffusion	coefficient	values	
within	the	tumor	and	metastatic	lymph	nodes	were	significantly	
1  Apparent Diffusion Coefficient 
lower	than	in	analogical	normal	healthy	structures,	which	results	
from	 morphological	 differences,	 especially	 tumor	 necrosis.	
In	 comparison	 to	 conventional	MR,	 the	 relative	value	of	ADC	
increases	sensitivity	from	25	to	83%,	with	no	significant	difference	
of	the	test	specificity,	which	was	98	and	99%,	respectively.		
Balleyguier	 et	 al.,	 [13]	 in	 the	 guidelines	 of	 the	 European	
Society	of	Urogenital	Radiology	also	recommend	to	incorporate	
the	diffusion	sequence	into	the	optimized	protocol	of	pelvic	MR
Dynamic imaging after administration of 
paramagnetic contrast agent.
Opinions	 on	 intravenous	 administration	 of	 paramagnetic	
contrast	agent	in	patients	with	cervical	cancer	vary	considerably.	
According	 to	 Sala	 et	 al.,	 [6],	 it	 is	 not	 necessary	 to	 administer	
paramagnetic	 contrast	 agent	 as	 it	 does	 not	 improve	 the	 test	
precision	 in	 comparison	 to	 the	 classic	 imaging	 in	T2-wieghted	
sequence.	However,	 the	 authors	 point	 to	 the	 fact	 that	 dynamic	
imaging	may	be	of	use	when	differentiating	between	infiltrative	
and	 post-surgical	 changes.	 Camisão	 et	 al.,	 [9],	 confirm	 these	
Figure 4. The tumor of the lesser pelvis (double arrow) and metastases in the lymph 
nodes (single arrow) in the diffusion weighted imaging (DWI). 
Figure 5. Contrast-enhanced tumor and surrounding structures suggesting 
infiltration of the parametrium.). 
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observations	and	note	that	dynamic	sequences	often	do	not	allow	
to	measure	 the	volume	of	 the	main	 lesion	and	 the	depth	of	 the	
cervical	stromal	infiltration	precisely.	Therefore,	they	should	not	
be	performed	routinely.
Nevertheless,	 the	 contrast	 medium	 administration	 may	 be	
useful	in	locating	fistula	in	an	advanced	stage	of	the	disease	or	
during	check-up	after	treatment	completion.	
Donaldson	et	 al.,	 [26],	 on	 the	basis	of	MR	documentation	
analysis	performed	before	and	after	completion	of	radiotherapy	
in	50	patients	with	cervical	cancer,	established	that	the	dynamic	
imaging	is	complementary	to	clinical	and	classic	MR	examination.	
Thus,	it	may	be	used	to	assess	microcirculation	within	the	tumor,	
including	tissue	vascularization	and	capillary	permeability,	what	
may	 in	 fact	 contribute	 to	 the	 treatment	 prognosis.	 Spensley	 et	
al.,	[5]	and	Ellingsen	et	al.,	[27]	had	reached	similar	conclusions	
and	Liyanage	et	al.,	[7]	add	that	dynamic	imaging	may	increase	
the	efficacy	of	detecting	very	small	tumors,	between	3.1-5.0	mm	
infiltration.	The	sensitivity	of	the	method	has	been	estimated	at	
92%,	 in	 comparison	with	 23%	 in	 case	 of	T2-weighted	 images	
without	 contrast	 enhancement.	 Small-volume	 lesions	 have	
significant	 enhancement	 at	 the	 early	phase	of	 the	 examination,	
when	 compared	 to	 slight	 enhancement	 of	 the	 normal	 cervical	
epithelium.	The	 authors	 also	 noted,	 in	 accordance	with	 earlier	
observations,	that	administration	of	contrast	medium	may	help	to	
differentiate	between	post-radiation	and	infiltrative	changes.
Yuh	et	al.,	[28],	after	analyzing	101	examinations	with	the	use	
of	diffusion	sequence	and	dynamic	imaging,	demonstrated	their	
usefulness	in	predicting	tumor	response	to	chemotherapy	on	the	
basis	of	tumor	vascularization	and	differences	in	lesion	volume	
during	 treatment.	The	authors	also	underline	 the	 importance	of	
the	discussed	methods	in	the	imaging	of	the	residual	tumor	after	
treatment	 completion	 –	 progression	 of	 tumor	 assessment	 and	
local	recurrence.
FIGO MR
I pre-invasive cancer
normal image
IA invasive cancer identified only microscopically.
IA1 measured invasion of the stroma ≤ 3 mm in depth and ≤ 7 mm in diameter 
IA2 measured invasion of the stroma > 3 mm but < 5mm in depth and ≤ 7 mm in diameter 
IB clinically visible lesion, infiltration confined to the cervix or preclinical lesion greater than Stage IA. 
lesion with medium intensity signal on a low-intensity signal of 
the cervical stroma 
IB1 clinically visible lesion ≤ 40 mm
IB2 clinically visible lesion > 40 mm
II
carcinoma extends beyond the cervix, but does not 
extend into the pelvic wall; it involves the vagina, but not 
as far as the lower third. 
IIA without parametrial invasion
loss of normal low-intensity signal of the vaginal fornix or the wall 
in the cervical cancer tumor 
 
IIA1 clinically visible lesion ≤ 40 mm
IIA2 clinically visible lesion > 40 mm 
IIB with obvious parametrial invasion with no extension to the pelvic wall with/without involvement of the vagina 
discontinuity of the hypointense rim of the cervix 
III tumor extends to the pelvic wall and/or involves lower third of the vagina 
IIIA tumor involves lower third of the vagina, with no extension to the pelvic wall 
loss of normal low-intensity signal of the lower third of the vaginal 
wall 
IIIB extension to the pelvic wall and/or hydronephrosis or non-functioning kidney 
infiltration of internal obturator, levator ani, piriformis and iliac 
muscles and adjacent iliac vessels; 
additional symptoms, i.e. enhanced signal of the pelvic floor 
intensity, hydronephrosis, ureteral extasia due to occlusion 
(primary tumor) or metastases to lymph nodes 
IV carcinoma has extended beyond the true pelvis or has involved the mucosa of the bladder or rectum 
The carcinoma has involved the mucosa of the bladder and/
or rectum, Spread of the growth to adjacent organs, spread to 
paraaortic and inguinal lymph nodes IVA
carcinoma has involved the mucosa of the bladder or 
rectum 
IVB spread to distant organs 
Table I. Staging of cervical cancer according to FIGO classification in relation to the magnetic resonance imaging. 
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Fat and water saturation sequences
Fat	 saturation	 MR	 sequence	 allows	 to	 differentiate	 focal	
lesions	 containing	 blood	 or	 lipids.	 It	 also	 enables	 to	 identify	
teratoma	and	endometriosis,	as	well	as	allows	to	assess	perirectal	
fat	 tissue	 and	 its	 infiltration	 in	patients	with	 advanced	cervical	
cancer	[29].
Magnetic resonance spectroscopy
Magnetic	 resonance	 spectroscopy	 technique	 (MRS)	 may	
be	a	useful	tool	both	in	preliminary	diagnosis	and	in	subsequent	
check-up	 tests	 after	 radiotherapy	 completion,	 especially	 when	
other	standard	diagnostic	methods	are	ambiguous	[30].	MRS	is	
applied	in	the	assessment	of	tumor	metabolic	profile.	The	proton	
spectrum	of	cervical	cancer	is	characterized	by	the	presence	of	a	
high	signal	typical	for	triglyceride,	that	may	be	used	as	marker	of	
neoplastic	process.	According	to	Da	Silva	et	al.,	[31]	the	method	
allows	 to	 recognize	 hyperplasia	 but	 it	 remains	 impossible	 to	
determine	 the	 exact	 nature	 of	 the	 neoplastic	 change,	 that	 is	 to	
differentiate	between	primary	and	metastatic	lesion.
Endovaginal coil 
Magnetic	 resonance	 with	 the	 use	 of	 endovaginal	 coil	 has	
high	 sensitivity	 in	preoperative	 imaging	of	 the	cervical	 cancer,	
especially	 for	 lesions	 in	 diameter	 below	 1cm3.	 The	 obtained	
results	 are	 important	 for	 treatment	 planning,	 particularly	 for	
patients	who	wish	to	preserve	their	fertility,	as	well	as	for	planning	
radical	surgical	treatment	at	an	early	stage	of	the	disease.	The	coil	
allows	to	assess	water	behavior	in	nontumor	and	tumor	structures	
[32].	Charles-Edwards	et	al.	[33],	after	analyzing	113	patients	in	
diffusion	sequence	concluded	that	the	endovaginal	coil	increases	
the	 precision	 of	 infiltration	 assessment	 at	 early	 stages	 of	 	 the	
cancer.
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